SCHEMBL19952210

SCHEMBL19952210

CNCCN1CCC(c2ccc3[nH]c(-c4ccncc4)c(C)c3c2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 20/20 1.00
TLR7 Q9NYK1 16/20 1.00
TLR8 Q9NR97 8/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19951886 0.89 TLR9 (1.00) TLR9TLR7TLR8
SCHEMBL29583843 0.89 TLR9 (1.00) TLR9TLR7TLR8
SCHEMBL19952456 0.89 TLR9 (1.00) TLR9TLR7TLR8
SCHEMBL19952425 0.88 TLR9 (1.00) TLR9TLR7TLR8
SCHEMBL19952264 0.88 TLR9 (1.00) TLR9TLR7TLR8
SCHEMBL19952610 0.87 TLR9 (1.00) TLR9TLR7TLR8
SCHEMBL19952342 0.86 TLR9 (1.00) TLR9TLR7TLR8
SCHEMBL29585499 0.86 TLR9 (0.78) TLR9TLR7TLR8
SCHEMBL22438014 0.85 TLR9 (0.77) TLR9TLR7TLR8
SCHEMBL29585486 0.85 TLR9 (1.00) TLR9TLR7TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109923108-B Pyridyl-substituted indole compounds 百时美施贵宝公司 2022-04-29 CN claimed
EP-3510024-B1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-11-17 EP claimed
US-10660877-B2 Pyridyl substituted indole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2020-05-26 US claimed
US-20190262311-A1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2019-08-29 US claimed
EP-3510024-A1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS Bristol-Myers Squibb Company (US) 2019-07-17 EP claimed
WO-2018049089-A1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-15 WO claimed
CN-109923108-B Pyridyl-substituted indole compounds 百时美施贵宝公司 2022-04-29 CN disclosed
EP-3510024-B1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-11-17 EP disclosed
EP-3510024-B1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-11-17 EP disclosed
US-10660877-B2 Pyridyl substituted indole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2020-05-26 US disclosed
US-10660877-B2 Pyridyl substituted indole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2020-05-26 US disclosed
US-20190262311-A1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2019-08-29 US disclosed
US-20190262311-A1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2019-08-29 US disclosed
EP-3510024-A1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS Bristol-Myers Squibb Company (US) 2019-07-17 EP disclosed
WO-2018049089-A1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190262311-A1 PYRIDYL SUBSTITUTED INDOLE COMPOUNDS TLR7, TLR9, TLR1 TLR9 2/4885TLR7 1/4885TLR8 4/4885
US-10660877-B2 Pyridyl substituted indole compounds TLR7, TLR9, TLR1 TLR9 2/4885TLR7 1/4885TLR8 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.